2-amino-3-phosphonopropionic acid and vasoactive intestinal peptide

2-amino-3-phosphonopropionic acid has been researched along with vasoactive intestinal peptide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magistretti, PJ; Martin, JL; Pellegri, G1

Other Studies

1 other study(ies) available for 2-amino-3-phosphonopropionic acid and vasoactive intestinal peptide

ArticleYear
VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones.
    The European journal of neuroscience, 1998, Volume: 10, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Alanine; Animals; Astrocytes; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Gene Expression; Glutamic Acid; Mice; Neuronal Plasticity; Neurons; Neuropeptides; Neurotransmitter Agents; Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Vasoactive Intestinal Peptide

1998